Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer
About this item
Full title
Author / Creator
Lips, Esther H. , Mukhtar, Rita A. , Yau, Christina , de Ronde, Jorma J. , Livasy, Chad , Carey, Lisa A. , Loo, Claudette E. , Vrancken-Peeters, Marie-Jeanne T. F. D. , Sonke, Gabe S. , Berry, Donald A. , van‘t Veer, Laura J. , Esserman, Laura J. , Wesseling, Jelle , Rodenhuis, Sjoerd , Shelley Hwang, E. and I-SPY TRIAL Investigators
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
Invasive lobular carcinoma (ILC) has been reported to be less responsive to neoadjuvant chemotherapy (NAC) than invasive ductal carcinoma (IDC). We sought to determine whether ILC histology indeed predicts poor response to NAC by analyzing tumor characteristics such as protein expression, gene expression, and imaging features, and by comparing NAC...
Alternative Titles
Full title
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer
Authors, Artists and Contributors
Author / Creator
Mukhtar, Rita A.
Yau, Christina
de Ronde, Jorma J.
Livasy, Chad
Carey, Lisa A.
Loo, Claudette E.
Vrancken-Peeters, Marie-Jeanne T. F. D.
Sonke, Gabe S.
Berry, Donald A.
van‘t Veer, Laura J.
Esserman, Laura J.
Wesseling, Jelle
Rodenhuis, Sjoerd
Shelley Hwang, E.
I-SPY TRIAL Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5702179
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5702179
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-012-2233-z
